NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/01/2025
Back to search
Official data from USPTO
SAREPTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
05/20/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
06/05/2012
Registration date
12/09/2014
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/01/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/12/2012
First use in commerce
10/15/2014
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
MAI, TINA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SAREPTA THERAPEUTICS, INC.
SAREPTA THERAPEUTICS, INC.
SAREPTA THERAPEUTICS, INC.
AVI BioPharma, Inc.
Representatives
Paul C. Llewellyn Arnold & Porter Kaye Scholer LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceuticals and pharmaceutical products for treating muscular dystrophy ((, infectious diseases and viruses that respond to ribonucleic acid (RNA)-based therapies )) ; pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression
Class 42
medical and scientific research services, namely, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies
Publications
History of USPTO decisions and trademark events.
56 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/01/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/01/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
12/04/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/09/2023
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
05/27/2021
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/27/2021
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
05/27/2021
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/27/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/27/2021
E15R
TEAS SECTION 15 RECEIVED
11/16/2020
ES8R
TEAS SECTION 8 RECEIVED
11/16/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/09/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/02/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/18/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/18/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/07/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/06/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/23/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/22/2014
EX3G
SOU EXTENSION 3 GRANTED
10/22/2014
IUAF
USE AMENDMENT FILED
10/15/2014
EXT3
SOU EXTENSION 3 FILED
10/15/2014
EEXT
SOU TEAS EXTENSION RECEIVED
10/15/2014
EISU
TEAS STATEMENT OF USE RECEIVED
10/15/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/29/2014
EX2G
SOU EXTENSION 2 GRANTED
04/28/2014
EXT2
SOU EXTENSION 2 FILED
04/16/2014
EEXT
SOU TEAS EXTENSION RECEIVED
04/16/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/19/2013
EX1G
SOU EXTENSION 1 GRANTED
11/18/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/12/2013
EXT1
SOU EXTENSION 1 FILED
10/10/2013
EEXT
SOU TEAS EXTENSION RECEIVED
10/10/2013
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/18/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/16/2013
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/16/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/16/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/19/2013
PUBO
PUBLISHED FOR OPPOSITION
02/19/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/30/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/12/2013
ALIE
ASSIGNED TO LIE
01/11/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/24/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/18/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/02/2012
GNRT
NON-FINAL ACTION E-MAILED
07/02/2012
CNRT
NON-FINAL ACTION WRITTEN
07/02/2012
DOCK
ASSIGNED TO EXAMINER
06/27/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/14/2012
NWAP
NEW APPLICATION ENTERED
06/08/2012
Continuous trademark protection
Get notified about every new filing that threatens SAREPTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.